Feature
Dynamic, Accessible Risk Stratification Tool Created for Smoldering Multiple Myeloma
-
By
-
March 27, 2026
-
4 min
By
March 27, 2026
by The ASCO Post Staff
March 27, 2026
Antibody proteomics and immunogenetics identify adenoviral protein VII as the trigger of PF4-targeting antibodies
April 21, 2026
New modeling study shows curative treatments may be viable in low-income settings if costs are scaled and societal benefits included
April 9, 2026
For myelofibrosis, the treatment landscape is poised for change as new targets have emerged, and treatments are evolving beyond the standard Janus kinase (JAK) inhibitors. Novel therapies are being pa...
March 24, 2026